- Home
- BCRX vs IMAX Comparison
BCRX vs IMAX Comparison
Compare BCRX & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCRX | IMAX |
|---|---|---|
| Founded | 1986 | 1967 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 1995 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BCRX | IMAX |
|---|---|---|
| Price | $8.02 | $51.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $20.73 | ★ $56.68 |
| AVG Volume (30 Days) | ★ 4.9M | 992.4K |
| Earning Date | 11-02-2026 | 10-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 31.25 |
| EPS | N/A | ★ 0.35 |
| Revenue | $25,186,000.00 | ★ $410,212,000.00 |
| Revenue This Year | N/A | $12.55 |
| Revenue Next Year | $4.02 | $4.89 |
| P/E Ratio | ★ N/A | $150.29 |
| Revenue Growth | N/A | ★ 16.47 |
| 52 Week Low | $6.00 | $30.74 |
| 52 Week High | $11.22 | $57.73 |
Technical Indicators
Market Signals| Indicator | BCRX | IMAX |
|---|---|---|
| Relative Strength Index (RSI) | 35.10 | 43.08 |
| Support Level | $6.35 | $50.03 |
| Resistance Level | $8.05 | $55.57 |
| Average True Range (ATR) | 0.30 | 1.99 |
| MACD | -0.02 | -0.41 |
| Stochastic Oscillator | 14.16 | 4.72 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.